5 research outputs found

    Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate

    No full text
    Peptide receptor radionuclide therapy (PRRT) is an efficient treatment for gastroenteropancreatic neuroendocrine tumors (GEP NETs), with outstanding overall response rates and survival. However, little is known about the particular efficacy regarding bone metastasis (BM)

    Literatur

    No full text

    Literaturverzeichnis

    No full text
    corecore